Global Alpha L-Iduronidase Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 113
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Alpha L-Iduronidase market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) – Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). The molecules developed by companies in Phase II, Preclinical and Discovery stages are 4, 6 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 1 molecules, respectively. Report covers products from therapy areas Genetic Disorders which include indications Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ).
The Global Info Research report includes an overview of the development of the Alpha L-Iduronidase industry chain, the market status of Oncology (IDUA, EC 3.2.1.76), Dermatology (IDUA, EC 3.2.1.76), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Alpha L-Iduronidase.
Regionally, the report analyzes the Alpha L-Iduronidase markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Alpha L-Iduronidase market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Alpha L-Iduronidase market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Alpha L-Iduronidase industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., IDUA, EC 3.2.1.76).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Alpha L-Iduronidase market.
Regional Analysis: The report involves examining the Alpha L-Iduronidase market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Alpha L-Iduronidase market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Alpha L-Iduronidase:
Company Analysis: Report covers individual Alpha L-Iduronidase manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Alpha L-Iduronidase This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Dermatology).
Technology Analysis: Report covers specific technologies relevant to Alpha L-Iduronidase. It assesses the current state, advancements, and potential future developments in Alpha L-Iduronidase areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Alpha L-Iduronidase market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Alpha L-Iduronidase market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
IDUA
EC 3.2.1.76
Market segment by Application
Oncology
Dermatology
Immunology
Musculoskeletal Disorders
Major players covered
ArmaGen Inc
BioStrategies LC
Denali Therapeutics Inc
EdiGene Inc
Gain Therapeutics Inc
Immusoft Corp
JCR Pharmaceuticals Co Ltd
Orchard Therapeutics Plc
Ossianix Inc
Rain Bio Inc
RegenxBio Inc
Tega Therapeutics Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alpha L-Iduronidase product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Alpha L-Iduronidase, with price, sales, revenue and global market share of Alpha L-Iduronidase from 2019 to 2024.
Chapter 3, the Alpha L-Iduronidase competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alpha L-Iduronidase breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Alpha L-Iduronidase market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Alpha L-Iduronidase.
Chapter 14 and 15, to describe Alpha L-Iduronidase sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Alpha L-Iduronidase
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Alpha L-Iduronidase Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 IDUA
1.3.3 EC 3.2.1.76
1.4 Market Analysis by Application
1.4.1 Overview: Global Alpha L-Iduronidase Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Dermatology
1.4.4 Immunology
1.4.5 Musculoskeletal Disorders
1.5 Global Alpha L-Iduronidase Market Size & Forecast
1.5.1 Global Alpha L-Iduronidase Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Alpha L-Iduronidase Sales Quantity (2019-2030)
1.5.3 Global Alpha L-Iduronidase Average Price (2019-2030)
2.1 ArmaGen Inc
2.1.1 ArmaGen Inc Details
2.1.2 ArmaGen Inc Major Business
2.1.3 ArmaGen Inc Alpha L-Iduronidase Product and Services
2.1.4 ArmaGen Inc Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 ArmaGen Inc Recent Developments/Updates
2.2 BioStrategies LC
2.2.1 BioStrategies LC Details
2.2.2 BioStrategies LC Major Business
2.2.3 BioStrategies LC Alpha L-Iduronidase Product and Services
2.2.4 BioStrategies LC Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 BioStrategies LC Recent Developments/Updates
2.3 Denali Therapeutics Inc
2.3.1 Denali Therapeutics Inc Details
2.3.2 Denali Therapeutics Inc Major Business
2.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Product and Services
2.3.4 Denali Therapeutics Inc Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Denali Therapeutics Inc Recent Developments/Updates
2.4 EdiGene Inc
2.4.1 EdiGene Inc Details
2.4.2 EdiGene Inc Major Business
2.4.3 EdiGene Inc Alpha L-Iduronidase Product and Services
2.4.4 EdiGene Inc Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 EdiGene Inc Recent Developments/Updates
2.5 Gain Therapeutics Inc
2.5.1 Gain Therapeutics Inc Details
2.5.2 Gain Therapeutics Inc Major Business
2.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Product and Services
2.5.4 Gain Therapeutics Inc Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Gain Therapeutics Inc Recent Developments/Updates
2.6 Immusoft Corp
2.6.1 Immusoft Corp Details
2.6.2 Immusoft Corp Major Business
2.6.3 Immusoft Corp Alpha L-Iduronidase Product and Services
2.6.4 Immusoft Corp Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Immusoft Corp Recent Developments/Updates
2.7 JCR Pharmaceuticals Co Ltd
2.7.1 JCR Pharmaceuticals Co Ltd Details
2.7.2 JCR Pharmaceuticals Co Ltd Major Business
2.7.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product and Services
2.7.4 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 JCR Pharmaceuticals Co Ltd Recent Developments/Updates
2.8 Orchard Therapeutics Plc
2.8.1 Orchard Therapeutics Plc Details
2.8.2 Orchard Therapeutics Plc Major Business
2.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Product and Services
2.8.4 Orchard Therapeutics Plc Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Orchard Therapeutics Plc Recent Developments/Updates
2.9 Ossianix Inc
2.9.1 Ossianix Inc Details
2.9.2 Ossianix Inc Major Business
2.9.3 Ossianix Inc Alpha L-Iduronidase Product and Services
2.9.4 Ossianix Inc Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Ossianix Inc Recent Developments/Updates
2.10 Rain Bio Inc
2.10.1 Rain Bio Inc Details
2.10.2 Rain Bio Inc Major Business
2.10.3 Rain Bio Inc Alpha L-Iduronidase Product and Services
2.10.4 Rain Bio Inc Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Rain Bio Inc Recent Developments/Updates
2.11 RegenxBio Inc
2.11.1 RegenxBio Inc Details
2.11.2 RegenxBio Inc Major Business
2.11.3 RegenxBio Inc Alpha L-Iduronidase Product and Services
2.11.4 RegenxBio Inc Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 RegenxBio Inc Recent Developments/Updates
2.12 Tega Therapeutics Inc
2.12.1 Tega Therapeutics Inc Details
2.12.2 Tega Therapeutics Inc Major Business
2.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Product and Services
2.12.4 Tega Therapeutics Inc Alpha L-Iduronidase Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Tega Therapeutics Inc Recent Developments/Updates
3.1 Global Alpha L-Iduronidase Sales Quantity by Manufacturer (2019-2024)
3.2 Global Alpha L-Iduronidase Revenue by Manufacturer (2019-2024)
3.3 Global Alpha L-Iduronidase Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Alpha L-Iduronidase by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Alpha L-Iduronidase Manufacturer Market Share in 2023
3.4.2 Top 6 Alpha L-Iduronidase Manufacturer Market Share in 2023
3.5 Alpha L-Iduronidase Market: Overall Company Footprint Analysis
3.5.1 Alpha L-Iduronidase Market: Region Footprint
3.5.2 Alpha L-Iduronidase Market: Company Product Type Footprint
3.5.3 Alpha L-Iduronidase Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Alpha L-Iduronidase Market Size by Region
4.1.1 Global Alpha L-Iduronidase Sales Quantity by Region (2019-2030)
4.1.2 Global Alpha L-Iduronidase Consumption Value by Region (2019-2030)
4.1.3 Global Alpha L-Iduronidase Average Price by Region (2019-2030)
4.2 North America Alpha L-Iduronidase Consumption Value (2019-2030)
4.3 Europe Alpha L-Iduronidase Consumption Value (2019-2030)
4.4 Asia-Pacific Alpha L-Iduronidase Consumption Value (2019-2030)
4.5 South America Alpha L-Iduronidase Consumption Value (2019-2030)
4.6 Middle East and Africa Alpha L-Iduronidase Consumption Value (2019-2030)
5.1 Global Alpha L-Iduronidase Sales Quantity by Type (2019-2030)
5.2 Global Alpha L-Iduronidase Consumption Value by Type (2019-2030)
5.3 Global Alpha L-Iduronidase Average Price by Type (2019-2030)
6.1 Global Alpha L-Iduronidase Sales Quantity by Application (2019-2030)
6.2 Global Alpha L-Iduronidase Consumption Value by Application (2019-2030)
6.3 Global Alpha L-Iduronidase Average Price by Application (2019-2030)
7.1 North America Alpha L-Iduronidase Sales Quantity by Type (2019-2030)
7.2 North America Alpha L-Iduronidase Sales Quantity by Application (2019-2030)
7.3 North America Alpha L-Iduronidase Market Size by Country
7.3.1 North America Alpha L-Iduronidase Sales Quantity by Country (2019-2030)
7.3.2 North America Alpha L-Iduronidase Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Alpha L-Iduronidase Sales Quantity by Type (2019-2030)
8.2 Europe Alpha L-Iduronidase Sales Quantity by Application (2019-2030)
8.3 Europe Alpha L-Iduronidase Market Size by Country
8.3.1 Europe Alpha L-Iduronidase Sales Quantity by Country (2019-2030)
8.3.2 Europe Alpha L-Iduronidase Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Alpha L-Iduronidase Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Alpha L-Iduronidase Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Alpha L-Iduronidase Market Size by Region
9.3.1 Asia-Pacific Alpha L-Iduronidase Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Alpha L-Iduronidase Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Alpha L-Iduronidase Sales Quantity by Type (2019-2030)
10.2 South America Alpha L-Iduronidase Sales Quantity by Application (2019-2030)
10.3 South America Alpha L-Iduronidase Market Size by Country
10.3.1 South America Alpha L-Iduronidase Sales Quantity by Country (2019-2030)
10.3.2 South America Alpha L-Iduronidase Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Alpha L-Iduronidase Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Alpha L-Iduronidase Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Alpha L-Iduronidase Market Size by Country
11.3.1 Middle East & Africa Alpha L-Iduronidase Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Alpha L-Iduronidase Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Alpha L-Iduronidase Market Drivers
12.2 Alpha L-Iduronidase Market Restraints
12.3 Alpha L-Iduronidase Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Alpha L-Iduronidase and Key Manufacturers
13.2 Manufacturing Costs Percentage of Alpha L-Iduronidase
13.3 Alpha L-Iduronidase Production Process
13.4 Alpha L-Iduronidase Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Alpha L-Iduronidase Typical Distributors
14.3 Alpha L-Iduronidase Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Alpha L-Iduronidase Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Alpha L-Iduronidase Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. ArmaGen Inc Basic Information, Manufacturing Base and Competitors
Table 4. ArmaGen Inc Major Business
Table 5. ArmaGen Inc Alpha L-Iduronidase Product and Services
Table 6. ArmaGen Inc Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. ArmaGen Inc Recent Developments/Updates
Table 8. BioStrategies LC Basic Information, Manufacturing Base and Competitors
Table 9. BioStrategies LC Major Business
Table 10. BioStrategies LC Alpha L-Iduronidase Product and Services
Table 11. BioStrategies LC Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. BioStrategies LC Recent Developments/Updates
Table 13. Denali Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 14. Denali Therapeutics Inc Major Business
Table 15. Denali Therapeutics Inc Alpha L-Iduronidase Product and Services
Table 16. Denali Therapeutics Inc Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Denali Therapeutics Inc Recent Developments/Updates
Table 18. EdiGene Inc Basic Information, Manufacturing Base and Competitors
Table 19. EdiGene Inc Major Business
Table 20. EdiGene Inc Alpha L-Iduronidase Product and Services
Table 21. EdiGene Inc Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. EdiGene Inc Recent Developments/Updates
Table 23. Gain Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 24. Gain Therapeutics Inc Major Business
Table 25. Gain Therapeutics Inc Alpha L-Iduronidase Product and Services
Table 26. Gain Therapeutics Inc Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Gain Therapeutics Inc Recent Developments/Updates
Table 28. Immusoft Corp Basic Information, Manufacturing Base and Competitors
Table 29. Immusoft Corp Major Business
Table 30. Immusoft Corp Alpha L-Iduronidase Product and Services
Table 31. Immusoft Corp Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Immusoft Corp Recent Developments/Updates
Table 33. JCR Pharmaceuticals Co Ltd Basic Information, Manufacturing Base and Competitors
Table 34. JCR Pharmaceuticals Co Ltd Major Business
Table 35. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product and Services
Table 36. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. JCR Pharmaceuticals Co Ltd Recent Developments/Updates
Table 38. Orchard Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table 39. Orchard Therapeutics Plc Major Business
Table 40. Orchard Therapeutics Plc Alpha L-Iduronidase Product and Services
Table 41. Orchard Therapeutics Plc Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Orchard Therapeutics Plc Recent Developments/Updates
Table 43. Ossianix Inc Basic Information, Manufacturing Base and Competitors
Table 44. Ossianix Inc Major Business
Table 45. Ossianix Inc Alpha L-Iduronidase Product and Services
Table 46. Ossianix Inc Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Ossianix Inc Recent Developments/Updates
Table 48. Rain Bio Inc Basic Information, Manufacturing Base and Competitors
Table 49. Rain Bio Inc Major Business
Table 50. Rain Bio Inc Alpha L-Iduronidase Product and Services
Table 51. Rain Bio Inc Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Rain Bio Inc Recent Developments/Updates
Table 53. RegenxBio Inc Basic Information, Manufacturing Base and Competitors
Table 54. RegenxBio Inc Major Business
Table 55. RegenxBio Inc Alpha L-Iduronidase Product and Services
Table 56. RegenxBio Inc Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. RegenxBio Inc Recent Developments/Updates
Table 58. Tega Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 59. Tega Therapeutics Inc Major Business
Table 60. Tega Therapeutics Inc Alpha L-Iduronidase Product and Services
Table 61. Tega Therapeutics Inc Alpha L-Iduronidase Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Tega Therapeutics Inc Recent Developments/Updates
Table 63. Global Alpha L-Iduronidase Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 64. Global Alpha L-Iduronidase Revenue by Manufacturer (2019-2024) & (USD Million)
Table 65. Global Alpha L-Iduronidase Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 66. Market Position of Manufacturers in Alpha L-Iduronidase, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 67. Head Office and Alpha L-Iduronidase Production Site of Key Manufacturer
Table 68. Alpha L-Iduronidase Market: Company Product Type Footprint
Table 69. Alpha L-Iduronidase Market: Company Product Application Footprint
Table 70. Alpha L-Iduronidase New Market Entrants and Barriers to Market Entry
Table 71. Alpha L-Iduronidase Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Alpha L-Iduronidase Sales Quantity by Region (2019-2024) & (K Units)
Table 73. Global Alpha L-Iduronidase Sales Quantity by Region (2025-2030) & (K Units)
Table 74. Global Alpha L-Iduronidase Consumption Value by Region (2019-2024) & (USD Million)
Table 75. Global Alpha L-Iduronidase Consumption Value by Region (2025-2030) & (USD Million)
Table 76. Global Alpha L-Iduronidase Average Price by Region (2019-2024) & (US$/Unit)
Table 77. Global Alpha L-Iduronidase Average Price by Region (2025-2030) & (US$/Unit)
Table 78. Global Alpha L-Iduronidase Sales Quantity by Type (2019-2024) & (K Units)
Table 79. Global Alpha L-Iduronidase Sales Quantity by Type (2025-2030) & (K Units)
Table 80. Global Alpha L-Iduronidase Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Global Alpha L-Iduronidase Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Global Alpha L-Iduronidase Average Price by Type (2019-2024) & (US$/Unit)
Table 83. Global Alpha L-Iduronidase Average Price by Type (2025-2030) & (US$/Unit)
Table 84. Global Alpha L-Iduronidase Sales Quantity by Application (2019-2024) & (K Units)
Table 85. Global Alpha L-Iduronidase Sales Quantity by Application (2025-2030) & (K Units)
Table 86. Global Alpha L-Iduronidase Consumption Value by Application (2019-2024) & (USD Million)
Table 87. Global Alpha L-Iduronidase Consumption Value by Application (2025-2030) & (USD Million)
Table 88. Global Alpha L-Iduronidase Average Price by Application (2019-2024) & (US$/Unit)
Table 89. Global Alpha L-Iduronidase Average Price by Application (2025-2030) & (US$/Unit)
Table 90. North America Alpha L-Iduronidase Sales Quantity by Type (2019-2024) & (K Units)
Table 91. North America Alpha L-Iduronidase Sales Quantity by Type (2025-2030) & (K Units)
Table 92. North America Alpha L-Iduronidase Sales Quantity by Application (2019-2024) & (K Units)
Table 93. North America Alpha L-Iduronidase Sales Quantity by Application (2025-2030) & (K Units)
Table 94. North America Alpha L-Iduronidase Sales Quantity by Country (2019-2024) & (K Units)
Table 95. North America Alpha L-Iduronidase Sales Quantity by Country (2025-2030) & (K Units)
Table 96. North America Alpha L-Iduronidase Consumption Value by Country (2019-2024) & (USD Million)
Table 97. North America Alpha L-Iduronidase Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Europe Alpha L-Iduronidase Sales Quantity by Type (2019-2024) & (K Units)
Table 99. Europe Alpha L-Iduronidase Sales Quantity by Type (2025-2030) & (K Units)
Table 100. Europe Alpha L-Iduronidase Sales Quantity by Application (2019-2024) & (K Units)
Table 101. Europe Alpha L-Iduronidase Sales Quantity by Application (2025-2030) & (K Units)
Table 102. Europe Alpha L-Iduronidase Sales Quantity by Country (2019-2024) & (K Units)
Table 103. Europe Alpha L-Iduronidase Sales Quantity by Country (2025-2030) & (K Units)
Table 104. Europe Alpha L-Iduronidase Consumption Value by Country (2019-2024) & (USD Million)
Table 105. Europe Alpha L-Iduronidase Consumption Value by Country (2025-2030) & (USD Million)
Table 106. Asia-Pacific Alpha L-Iduronidase Sales Quantity by Type (2019-2024) & (K Units)
Table 107. Asia-Pacific Alpha L-Iduronidase Sales Quantity by Type (2025-2030) & (K Units)
Table 108. Asia-Pacific Alpha L-Iduronidase Sales Quantity by Application (2019-2024) & (K Units)
Table 109. Asia-Pacific Alpha L-Iduronidase Sales Quantity by Application (2025-2030) & (K Units)
Table 110. Asia-Pacific Alpha L-Iduronidase Sales Quantity by Region (2019-2024) & (K Units)
Table 111. Asia-Pacific Alpha L-Iduronidase Sales Quantity by Region (2025-2030) & (K Units)
Table 112. Asia-Pacific Alpha L-Iduronidase Consumption Value by Region (2019-2024) & (USD Million)
Table 113. Asia-Pacific Alpha L-Iduronidase Consumption Value by Region (2025-2030) & (USD Million)
Table 114. South America Alpha L-Iduronidase Sales Quantity by Type (2019-2024) & (K Units)
Table 115. South America Alpha L-Iduronidase Sales Quantity by Type (2025-2030) & (K Units)
Table 116. South America Alpha L-Iduronidase Sales Quantity by Application (2019-2024) & (K Units)
Table 117. South America Alpha L-Iduronidase Sales Quantity by Application (2025-2030) & (K Units)
Table 118. South America Alpha L-Iduronidase Sales Quantity by Country (2019-2024) & (K Units)
Table 119. South America Alpha L-Iduronidase Sales Quantity by Country (2025-2030) & (K Units)
Table 120. South America Alpha L-Iduronidase Consumption Value by Country (2019-2024) & (USD Million)
Table 121. South America Alpha L-Iduronidase Consumption Value by Country (2025-2030) & (USD Million)
Table 122. Middle East & Africa Alpha L-Iduronidase Sales Quantity by Type (2019-2024) & (K Units)
Table 123. Middle East & Africa Alpha L-Iduronidase Sales Quantity by Type (2025-2030) & (K Units)
Table 124. Middle East & Africa Alpha L-Iduronidase Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Middle East & Africa Alpha L-Iduronidase Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Middle East & Africa Alpha L-Iduronidase Sales Quantity by Region (2019-2024) & (K Units)
Table 127. Middle East & Africa Alpha L-Iduronidase Sales Quantity by Region (2025-2030) & (K Units)
Table 128. Middle East & Africa Alpha L-Iduronidase Consumption Value by Region (2019-2024) & (USD Million)
Table 129. Middle East & Africa Alpha L-Iduronidase Consumption Value by Region (2025-2030) & (USD Million)
Table 130. Alpha L-Iduronidase Raw Material
Table 131. Key Manufacturers of Alpha L-Iduronidase Raw Materials
Table 132. Alpha L-Iduronidase Typical Distributors
Table 133. Alpha L-Iduronidase Typical Customers
List of Figures
Figure 1. Alpha L-Iduronidase Picture
Figure 2. Global Alpha L-Iduronidase Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Alpha L-Iduronidase Consumption Value Market Share by Type in 2023
Figure 4. IDUA Examples
Figure 5. EC 3.2.1.76 Examples
Figure 6. Global Alpha L-Iduronidase Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Alpha L-Iduronidase Consumption Value Market Share by Application in 2023
Figure 8. Oncology Examples
Figure 9. Dermatology Examples
Figure 10. Immunology Examples
Figure 11. Musculoskeletal Disorders Examples
Figure 12. Global Alpha L-Iduronidase Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Alpha L-Iduronidase Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Alpha L-Iduronidase Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Alpha L-Iduronidase Average Price (2019-2030) & (US$/Unit)
Figure 16. Global Alpha L-Iduronidase Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Alpha L-Iduronidase Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Alpha L-Iduronidase by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Alpha L-Iduronidase Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Alpha L-Iduronidase Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Alpha L-Iduronidase Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Alpha L-Iduronidase Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Alpha L-Iduronidase Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Alpha L-Iduronidase Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Alpha L-Iduronidase Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Alpha L-Iduronidase Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Alpha L-Iduronidase Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Alpha L-Iduronidase Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Alpha L-Iduronidase Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Alpha L-Iduronidase Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Alpha L-Iduronidase Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Alpha L-Iduronidase Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Alpha L-Iduronidase Average Price by Application (2019-2030) & (US$/Unit)
Figure 34. North America Alpha L-Iduronidase Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Alpha L-Iduronidase Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Alpha L-Iduronidase Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Alpha L-Iduronidase Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Alpha L-Iduronidase Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Alpha L-Iduronidase Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Alpha L-Iduronidase Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Alpha L-Iduronidase Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Alpha L-Iduronidase Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Alpha L-Iduronidase Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Alpha L-Iduronidase Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Alpha L-Iduronidase Consumption Value Market Share by Region (2019-2030)
Figure 54. China Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Alpha L-Iduronidase Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Alpha L-Iduronidase Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Alpha L-Iduronidase Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Alpha L-Iduronidase Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Alpha L-Iduronidase Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Alpha L-Iduronidase Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Alpha L-Iduronidase Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Alpha L-Iduronidase Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Alpha L-Iduronidase Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Alpha L-Iduronidase Market Drivers
Figure 75. Alpha L-Iduronidase Market Restraints
Figure 76. Alpha L-Iduronidase Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Alpha L-Iduronidase in 2023
Figure 79. Manufacturing Process Analysis of Alpha L-Iduronidase
Figure 80. Alpha L-Iduronidase Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
ArmaGen Inc BioStrategies LC Denali Therapeutics Inc EdiGene Inc Gain Therapeutics Inc Immusoft Corp JCR Pharmaceuticals Co Ltd Orchard Therapeutics Plc Ossianix Inc Rain Bio Inc RegenxBio Inc Tega Therapeutics Inc
Related Reports
26 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
